Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59
United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Arthur Kuan
12 Mar 2026
Chief Executive Officer
Exercised, kept
64,612
$1.72
$111.13K
Arthur Kuan
4 Mar 2026
Chief Executive Officer
Exercised, kept
102,871
$1.72
$176.94K

What was left out

Form 4 filings counted 76
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 38
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,248,735
History held since 26 Jan 2024